医学
高脂血症
肥胖
疾病
糖尿病
转化研究
赛马鲁肽
临床研究
基础研究
生物信息学
2型糖尿病
内科学
内分泌学
生物
计算机科学
利拉鲁肽
病理
图书馆学
摘要
With the improvement of people's quality of life and the modern sub-healthy lifestyle, the proportion of diseases including diabetes, obesity, hypertension, hyperlipidemia, and coronary heart disease caused by them has significantly increased in the population. GIP and GLP-1 and are both important targets for the treatment of TIID and obesity and have attracted increasing attention in both basic and clinical research. This article mainly discusses the mechanisms of GLP-1 and GIP, two intestinal hormones, in TIID, obesity, and the immune system, as well as their roles in metabolism. It also provides an overview of the clinical effects of related drugs, such as semaglutide and dual receptor agonists. This article has guiding significance for future basic research and clinical medication and underscores the importance of comprehensive research in GLP pharmacology to optimize GLP-targeted drug development and clinical outcomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI